BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TOP1, RP3-511B24_2, 7150, ENSG00000198900, TOPI, P11387 AND Prognosis
12189 results:

  • 1. Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients.
    Thonusin C; Osataphan N; Leemasawat K; Nawara W; Sriwichaiin S; Supakham S; Gunaparn S; Apaijai N; Somwangprasert A; Phrommintikul A; Chattipakorn SC; Chattipakorn N
    J Transl Med; 2024 Apr; 22(1):398. PubMed ID: 38685030
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-Noncoding-RNA HOTAIR Upregulation is Associated with Poor breast cancer Outcome: A Systematic Review and Meta Analysis.
    Suwardjo S; Gilang Permana K; Aryandono T; Heriyanto DS; Anwar SL
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1169-1182. PubMed ID: 38679975
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B breast cancer: A Pilot Study.
    Camargo-Herrera V; Castellanos G; Rangel N; Jiménez-Tobón GA; Martínez-Agüero M; Rondón-Lagos M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674062
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The relationship of changes in molecular subtypes with metastases and progression-free survival in breast cancer.
    Amansyah F; Prihantono P; Hamid F; Syamsu SA; Pieter J; Faruk M
    Breast Dis; 2024; 43(1):71-78. PubMed ID: 38669518
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Lateral lymph node metastasis in papillary thyroid cancer: Is there a difference between PTC and PTMC?
    Ma W; Guo Y; Hua T; Li L; Lv T; Wang J
    Medicine (Baltimore); 2024 Apr; 103(17):e37734. PubMed ID: 38669400
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of Pregnancy on breast cancer Features and prognosis.
    Bounous VE; Minella C; Fuso L; Actis S; Petroni G; Sgrò LG; Borghese M; Tomasi Cont N; Ponzone R; Ferrero A
    Curr Oncol; 2024 Apr; 31(4):2305-2315. PubMed ID: 38668074
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The evolvement of breast cancer therapies: What we have done and where all these head off.
    Nurlaila I; Pambudi S
    Saudi Med J; 2024 Apr; 45(4):331-340. PubMed ID: 38657992
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling.
    Wang S; Li J; Hong S; Wang N; Xu S; Yang B; Zheng Y; Zhang J; Pan B; Hu Y; Wang Z
    J Exp Clin Cancer Res; 2024 Apr; 43(1):121. PubMed ID: 38654356
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissue in evaluating prognosis of elderly breast cancer patients after modified radical mastectomy.
    Lv J; Zhang J; Wu F
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):254-259. PubMed ID: 38650158
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Role of neoadjuvant rectal score in prognosis and adjuvant chemotherapy decision-making in locally advanced rectal cancer following neoadjuvant short-course radiotherapy and consolidation chemotherapy].
    Zeng Q; Tang Y; Zhou HT; Li N; Liu WY; Chen SL; Li S; Lu NN; Fang H; Wang SL; Liu YP; Song YW; Li YX; Jin J
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):335-343. PubMed ID: 38644269
    [No Abstract]    [Full Text] [Related]  

  • 11. Postpartum breast cancer and Survival in Women With Germline BRCA Pathogenic Variants.
    Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
    JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathological Significance of Tumor Budding in breast Carcinoma.
    Buch A; Jain K; Rathod H; Gore C
    J Nepal Health Res Counc; 2024 Mar; 21(3):417-427. PubMed ID: 38615212
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum Levels of Copper and Zinc and Survival in breast cancer Patients.
    Szwiec M; Marciniak W; Derkacz R; Huzarski T; Gronwald J; Cybulski C; Dębniak T; Jakubowska A; Lener MR; Falco M; Kładny J; Baszuk P; Kotsopoulos J; Narod SA; Lubiński J
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613033
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. B7-H3 Expression in breast cancer and Brain Metastasis.
    Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. 3-NAntC: A Potent Crotoxin B-Derived Peptide against the Triple-Negative MDA-MB-231 breast cancer Cell Line.
    Bezerra P; Motti EF
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611925
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates.
    Bae SJ; Kook Y; Jang JS; Baek SH; Moon S; Kim JH; Lee SE; Kim MJ; Ahn SG; Jeong J
    Breast Cancer Res; 2024 Apr; 26(1):65. PubMed ID: 38609935
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
    Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
    Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mitochondrial Ca
    De Mario A; Trevellin E; Piazza I; Vindigni V; Foletto M; Rizzuto R; Vettor R; Mammucari C
    Sci Rep; 2024 Apr; 14(1):8469. PubMed ID: 38605098
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.
    Karihtala P; Leivonen SK; Puistola U; Urpilainen E; Jääskeläinen A; Leppä S; Jukkola A
    Breast Cancer Res; 2024 Apr; 26(1):61. PubMed ID: 38594742
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics.
    Song Y; Ren S; Chen X; Li X; Chen L; Zhao S; Zhang Y; Shen X; Chen Y
    Cancer Lett; 2024 May; 590():216847. PubMed ID: 38583647
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 610.